Precision therapies take aim at non-Hodgkin’s lymphoma
Elie Dolgin • November 14, 2018
The dramatic success of ibrutinib has created a more hopeful reality for people with lymphoma, as targeted therapies fill the pipeline.
Continue reading here.
A closer listen to lion calls may help map where the big cat is under threat.
Scientists remain split on whether rope-pulling ingenuity counts as tool use.